Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-01 Sale |
2022-03-03 4:39 pm |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
6,200 | $24 | $148,800 | 515,343 (Direct) |
View |
| 2021-12-23 Sale |
2021-12-28 4:13 pm |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $24 | $74,400 | 521,543 (Direct) |
View |
| 2021-11-18 Sale |
2021-11-22 4:58 pm |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $24.53 | $76,031 | 524,643 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-03-02 Option Award |
2022-03-04 8:51 pm |
N/A 2032-03-01 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
262,500 | $0 | 265,625 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:39 pm |
N/A 2030-05-11 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
6,200 | $0 | 515,343 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 4:39 pm |
N/A N/A |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
6,200 | $5.35 | 515,343 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:13 pm |
N/A 2030-05-11 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $0 | 521,543 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-28 4:13 pm |
N/A N/A |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $5.35 | 521,543 (Direct) |
View |
| 2021-12-20 Option Award |
2021-12-21 5:25 pm |
N/A 2031-12-19 |
Caribou Biosciences Inc. | CRBU | GUGGENHIME ANDREW Director |
27,500 | $0 | 27,500 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 4:58 pm |
N/A 2030-05-11 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $0 | 524,643 (Direct) |
View |
| 2021-11-18 Exercise |
2021-11-22 4:58 pm |
N/A N/A |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
3,100 | $5.35 | 524,643 (Direct) |
View |
Ownership |
2021-07-22 9:00 pm |
N/A 2031-05-27 |
Caribou Biosciences Inc. | CRBU | GUGGENHIME ANDREW Director |
0 | $0 | 87,440 (Direct) |
View |
| 2021-05-24 Option Award |
2021-05-25 6:55 pm |
N/A 2031-05-23 |
Metacrine Inc. | MTCR | GUGGENHIME ANDREW Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-06 8:02 pm |
N/A 2031-03-31 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW President and CFO |
145,000 | $0 | 145,000 (Direct) |
View |
Ownership |
2020-09-15 4:55 pm |
N/A 2028-07-08 |
Metacrine Inc. | MTCR | GUGGENHIME ANDREW Director |
0 | $0 | 74,116 (Direct) |
View |
Ownership |
2020-06-11 7:38 pm |
N/A 2030-05-11 |
Vaxcyte Inc. | PCVX | GUGGENHIME ANDREW CFO, CBO |
0 | $0 | 524,618 (Direct) |
View |